SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.
Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y, Zhang S, Fan Z, Dong J, Yuan Z, Ding Z, Zhang Y, Hu L. · 2020
Read SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. by Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y, Zhang S, Fan Z, Dong J, Yuan Z, Ding Z, Zhang Y, Hu L. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7471641.txt.
Description
Zhang and co-authors show that SARS-CoV-2 can bind platelet ACE2 and boost clotting in COVID-19. Critically ill patients often enter a pro-clotting state with lethal risk. The role of platelets in the disease was unclear.
Patients with COVID-19 had larger, overactive platelets and lower platelet counts. Virus RNA in blood tracked with platelet overactivity in the sickest patients. Platelets carry ACE2 and TMPRSS2, the tools the virus uses to enter cells. The virus and its spike protein directly fired platelet clumping, secretion, and clot shrinkage in lab tests. In mice, spike protein sped clot growth through human ACE2 platelets. Blocking spike or adding ACE2 protein cut the effect. The work names a direct route to COVID-19 clots.
Catalog record
| CREATOR | Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y, Zhang S, Fan Z, Dong J, Yuan Z, Ding Z, Zhang Y, Hu L. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |